Virtual Surgical Planning Systems in Mandibular Reconstruction

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Summary

The purpose of this study was to evaluate the accuracy of virtual planning using customized surgical devices (VP3D) in fibula free flap mandibular reconstruction. Virtual planning was compared to postoperative scans using cephalometric and three-dimensional (3D) measurements. Operative times of both VP3D and conventional surgery groups were compared.

See also
Status	Clinical Trial	Phase
Completed	`NCT03057223` - Three-Dimensional Printing of Patient-Specific Titanium Plates in Jaw Surgery: A Pilot Study	N/A
Completed	`NCT02745288` - Inferior Alveolar Nerve Block for Intraoperative Analgesia for Maxillofacial Cancer Surgery - RCT	N/A
Recruiting	`NCT04635865` - 3D-Printed Patient-Specific Surgical Plates Versus Conventional Surgical Plates in Jaw Reconstruction	N/A

NCT number	NCT03869723
Study type	Observational
Source	Hospices Civils de Lyon
Contact
Status	Completed
Phase
Start date	November 1, 2017
Completion date	March 31, 2018

Virtual Surgical Planning Systems in Mandibular Reconstruction — VP3D

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms